drugset / Trial / NCT01830140
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
This safety study will evaluate bimatoprost 0.01% and 0.03% in patients with glaucoma or ocular hypertension (OHT).
Timeline
- Start
- 2013-07
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | 0.01 % | — |
| Subject | Bimatoprost | Other / unclassified | 0.03 % | — |